NCT03531021 is a NA clinical trial of Heart healthy intervention in Type1diabetes, sponsored by Joslin Diabetes Center.

Who is sponsoring NCT03531021?

NCT03531021 is sponsored by Joslin Diabetes Center.

What drugs are being tested in NCT03531021?

Interventions in NCT03531021: Heart healthy intervention.

What condition does NCT03531021 study?

NCT03531021 studies Type1diabetes, Cardiovascular Risk Factor.

Is NCT03531021 still recruiting?

NCT03531021 is currently completed. Last updated 10 August 2021.

Last reviewed 2021-08-10 · How we verify

NCT03531021

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Increasing Heart Healthy Behaviors in Youth With Type 1 Diabetes

Completed NA Last updated 10 August 2021

What this trial tests

NA trial testing Heart healthy intervention in Type1diabetes in 45 participants. Completed in 8 February 2019.

Timeline

3 May 2018

Primary endpoint
8 February 2019

8 February 2019

Quick facts

Lead sponsor	Joslin Diabetes Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	45
Start date	3 May 2018
Primary completion	8 February 2019
Estimated completion	8 February 2019
Sites	1 location across United States

Drugs / interventions tested

Heart healthy intervention

Conditions studied

Type1diabetes — all drugs for Type1diabetes →
Cardiovascular Risk Factor — all drugs for Cardiovascular Risk Factor →

Sponsor

Joslin Diabetes Center — full company profile →

Who can join

Adults 14 to 19, any sex, with Type1diabetes or Cardiovascular Risk Factor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is evaluating how to encourage teens to engage in heart healthy behaviors such as being more active or eating in a healthy way. Teens will be randomly assigned to either the usual care group or the group with education, goal-setting, and lifestyle challenges with teammates.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Randomized Pilot Trial Using Mobile Health and Financial Incentives to Motivate Heart-Healthy Behaviors in Adolescents With Type 1 Diabetes.
Maxwell TK, Charmant CO, Volkening LK, Laffel LM, et al · · 2023 · cited 3× · PMID 36824050 · DOI 10.1177/19322968231155151

Verify or expand the search:

Other recruiting trials for Type1diabetes

Currently open trials in the same condition.

NCT07139808 — Safety and Effectiveness of A Novel Continuous Glucose and Ketone Monitoring System · NA · recruiting
NCT07092761 — Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System · NA · recruiting
NCT06646107 — Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There · recruiting
NCT06753994 — Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors · Phase 1 · recruiting
NCT05668507 — REACHOUT Mental Health Support Mobile App · NA · active not recruiting

Other Joslin Diabetes Center trials

Trials by the same sponsor.

NCT07271043 — Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incre · NA · recruiting
NCT07467694 — Postnatal Exercise to Activate Baby's Brown Fat · NA · recruiting
NCT06511310 — Exercise, Brain Activity, and Weight Maintenance · NA · recruiting
NCT07082478 — External Carotid Blood Flow in Individuals With Post-Bariatric Hypoglycemia · recruiting
NCT07468188 — Diabetes Body Project 2 · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03531021 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Joslin Diabetes Center
Last refreshed: 10 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03531021.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing